We are international
Donate
• health professionals TEXT SIZE   
   back

KOS 2007: Gene Expression Profiles as Prognostic Factors for High-Dose Therapy and Bortezomib in Patients with Multiple Myeloma
Annemiek Broyl, MD
Department of Hematology
Erasmus Medical Center
Rotterdam, The Netherlands
07.13.07

Be the first to comment

 related articles